Titan Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Five
Titan Pharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Five of $2.50 million as of 2011-11-14, per its 10-Q filed 2013-05-15.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2013-05-15
- 2011-11-14: Long-Term Debt, Maturity, Year Five $2.50M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2011-11-14 | $2.50M 10-Q · filed 2013-05-15 |